Diepalrestat choline: Completed Phase IIb enrollment

BioNevia and NeuroMax completed enrollment of 400 patients in the double-blind, placebo-controlled,

Read the full 123 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE